Real-world filgotinib study tracks arthritis control over 2 years

NCT ID NCT05323591

Completed Disease control Sponsor: Alfasigma S.p.A. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study followed 155 French adults with moderate-to-severe rheumatoid arthritis who were prescribed filgotinib (Jyseleca) for the first time. Over two years, researchers measured how many patients stayed on the drug and how well it controlled their disease activity. The goal was to see if filgotinib works as well in everyday clinics as it does in controlled trials.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Filgotinib (Jyseleca)
What this could lead to: If successful, this study could confirm that filgotinib works well in everyday practice for controlling rheumatoid arthritis symptoms and slowing joint damage.
What could go wrong: This is an observational study, not a controlled trial, so results may be influenced by patient selection or other factors. It does not prove filgotinib is better than other treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

rheumatoid arthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RHEUMATOID ARTHRITIS

Contacts and locations

Locations

CH de Cahors

Cahors, 46005, France
CHRU de Tours

Tours, 37044, France
CHU Amiens Picardie site Nord

Amiens, 80054, France
CHU Bordeaux

Bordeaux, 33000, France
CHU Toulouse

Toulouse, 31000, France
CHU de Amiens Picardie

Amiens, 80054, France
CHU de Nice

Nice, 06000, France
CHU de Rouen

Rouen, 76000, France
Centre Hospitalier Régional d'Orléans

Orléans, 45100, France
Centre Hospitalier Universitaire de Saint Etienne

Saint-Etienne, 42000, France
Clinique de l'Infirmerie Protestante de Lyon

Caluire-et-Cuire, 69300, France
Hopital Avicenne AP-HP

Bobigny, 93000, France
Hopital Cochin Service A

Paris, 75014, France
Hopital Robert Debre

Reims, 51092, France
Hopital Roger Salengro

Lille, 59037, France
Hopital Saint Antoine

Paris, 75012, France
Hopital Sud Francilien Corbeil Essonne

Corbeil-Essonnes, 91106, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.